On Monday, Nestle announced it would be acquiring Atrium Innovations for an amount of $2.3bn. Atrium Innovations is a maker of vitamins, probiotics and meal replacements and currently sources 80% of its $700mn in sales from the United States. From Nestle’s side, the deal aims to expand the group’s presence in consumer healthcare as well as offset weakness in packaged foods. The acquisition is in-line with Nestle’s ambition of becoming a nutrition, health and wellness company. Given Nestle’s decision to make consumer health a strategic priority, this marks the group’s fourth purchase in recent months.